ITEMS IN AFP WITH KEYWORD:
Jul 15, 2015 Issue
Screening for Cognitive Impairment in Older Adults [Putting Prevention into Practice]
N.D. is a 72-year-old white man who presents for a preventive visit. He smokes, and his medical history is significant for essential hypertension, which is stable and well controlled with medication. N.D.'s close friend was recently diagnosed with dementia, and N.D. is concerned that he may receive ...
Mar 15, 2015 Issue
Screening for Cognitive Impairment in Older Adults: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment.
Benzodiazepine exposure over the preceding five years seems to be associated with an increased likelihood of an Alzheimer disease diagnosis. A dose-response gradient also seems to exist.
Sep 1, 2014 Issue
Exercise Programs for Older Patients with Dementia [Cochrane for Clinicians]
There is some evidence that exercise improves cognitive function and the ability to perform activities of daily living in patients with dementia.
Jun 1, 2014 Issue
Should Family Physicians Routinely Screen Patients for Cognitive Impairment? Yes: Screening Is the First Step Toward Improving Care [Editorials: Controversies in Family Medicine]
Being able to anticipate and mitigate the potentially adverse outcomes of hospitalization in these patients should be reason enough to screen for cognitive impairment in the primary care setting.
Jun 1, 2014 Issue
Should Family Physicians Routinely Screen Patients for Cognitive Impairment? No: Screening Has Been Inappropriately Urged Despite Absence of Evidence [Editorials: Controversies in Family Medicine]
Dementia screening should not be exempt from the requirement that it first be shown to improve outcomes before being implemented in practice.
What are the effects of treatments on cognitive, behavioral, and psychological symptoms of dementia (Alzheimer disease, Lewy body dementia, or vascular dementia)?
Calcium plus vitamin D is no better than placebo in preventing cognitive decline in women older than 65 years.
Jan 1, 2012 Issue
Antidepressants for Agitation and Psychosis in Patients with Dementia [Cochrane for Clinicians]
There are few high-quality studies examining the effectiveness of antidepressants for treating the neuropsychiatric symptoms of dementia. Although there is some evidence to support the use of the selective serotonin reuptake inhibitors (SSRIs) sertraline (Zoloft) and citalopram (Celexa), they should...
As the proportion of persons in the United States older than 65 years increases, the prevalence of dementia will increase as well. Risk factors for dementia include age, family history of dementia, apolipoprotein E4 genotype, cardiovascular comorbidities, chronic anticholinergic use, and lower educa...